Genentech is a major biotechnology company that develops and sells medicines. According to its filings, it lobbies Congress on health and government insurance programs, especially drug pricing, the 340B Drug Discount Program, and implementation of the Inflation Reduction Act of 2022 as they affect Medicare and Medicaid. It has hired Rivendell Group LLP for this work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr MATTHEW LAWRENCE BERZOK
The latest disclosures for this client.
RIVENDELL GROUP LLP
1TRIVENDELL GROUP LLP
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
RIVENDELL GROUP LLP
NICK KOLOVOS
RIVENDELL GROUP LLP
RIVENDELL GROUP LLP
Q3RIVENDELL GROUP LLP
Q2RIVENDELL GROUP LLP
Q1